308 related articles for article (PubMed ID: 32414921)
1. Multivalent assembly of KRAS with the RAS-binding and cysteine-rich domains of CRAF on the membrane.
Fang Z; Lee KY; Huo KG; Gasmi-Seabrook G; Zheng L; Moghal N; Tsao MS; Ikura M; Marshall CB
Proc Natl Acad Sci U S A; 2020 Jun; 117(22):12101-12108. PubMed ID: 32414921
[TBL] [Abstract][Full Text] [Related]
2. Crystal Structure Reveals the Full Ras-Raf Interface and Advances Mechanistic Understanding of Raf Activation.
Cookis T; Mattos C
Biomolecules; 2021 Jul; 11(7):. PubMed ID: 34356620
[TBL] [Abstract][Full Text] [Related]
3. KRAS interaction with RAF1 RAS-binding domain and cysteine-rich domain provides insights into RAS-mediated RAF activation.
Tran TH; Chan AH; Young LC; Bindu L; Neale C; Messing S; Dharmaiah S; Taylor T; Denson JP; Esposito D; Nissley DV; Stephen AG; McCormick F; Simanshu DK
Nat Commun; 2021 Feb; 12(1):1176. PubMed ID: 33608534
[TBL] [Abstract][Full Text] [Related]
4. Raf-1 Cysteine-Rich Domain Increases the Affinity of K-Ras/Raf at the Membrane, Promoting MAPK Signaling.
Li S; Jang H; Zhang J; Nussinov R
Structure; 2018 Mar; 26(3):513-525.e2. PubMed ID: 29429878
[TBL] [Abstract][Full Text] [Related]
5. Exploring CRD mobility during RAS/RAF engagement at the membrane.
Nguyen K; López CA; Neale C; Van QN; Carpenter TS; Di Natale F; Travers T; Tran TH; Chan AH; Bhatia H; Frank PH; Tonelli M; Zhang X; Gulten G; Reddy T; Burns V; Oppelstrup T; Hengartner N; Simanshu DK; Bremer PT; Chen D; Glosli JN; Shrestha R; Turbyville T; Streitz FH; Nissley DV; Ingólfsson HI; Stephen AG; Lightstone FC; Gnanakaran S
Biophys J; 2022 Oct; 121(19):3630-3650. PubMed ID: 35778842
[TBL] [Abstract][Full Text] [Related]
6. Molecular recognition of RAS/RAF complex at the membrane: Role of RAF cysteine-rich domain.
Travers T; López CA; Van QN; Neale C; Tonelli M; Stephen AG; Gnanakaran S
Sci Rep; 2018 May; 8(1):8461. PubMed ID: 29855542
[TBL] [Abstract][Full Text] [Related]
7. Anionic Lipids Impact RAS-Binding Site Accessibility and Membrane Binding Affinity of CRAF RBD-CRD.
Travers T; López CA; Agamasu C; Hettige JJ; Messing S; García AE; Stephen AG; Gnanakaran S
Biophys J; 2020 Aug; 119(3):525-538. PubMed ID: 32649863
[TBL] [Abstract][Full Text] [Related]
8. Elucidation of binding determinants and functional consequences of Ras/Raf-cysteine-rich domain interactions.
Williams JG; Drugan JK; Yi GS; Clark GJ; Der CJ; Campbell SL
J Biol Chem; 2000 Jul; 275(29):22172-9. PubMed ID: 10777480
[TBL] [Abstract][Full Text] [Related]
9. The strength of interaction at the Raf cysteine-rich domain is a critical determinant of response of Raf to Ras family small GTPases.
Okada T; Hu CD; Jin TG; Kariya K; Yamawaki-Kataoka Y; Kataoka T
Mol Cell Biol; 1999 Sep; 19(9):6057-64. PubMed ID: 10454553
[TBL] [Abstract][Full Text] [Related]
10. Three distinct regions of cRaf kinase domain interact with membrane.
Prakash P; Hancock JF; Gorfe AA
Sci Rep; 2019 Feb; 9(1):2057. PubMed ID: 30765804
[TBL] [Abstract][Full Text] [Related]
11. Conformation-specific inhibitors of activated Ras GTPases reveal limited Ras dependency of patient-derived cancer organoids.
Wiechmann S; Maisonneuve P; Grebbin BM; Hoffmeister M; Kaulich M; Clevers H; Rajalingam K; Kurinov I; Farin HF; Sicheri F; Ernst A
J Biol Chem; 2020 Apr; 295(14):4526-4540. PubMed ID: 32086379
[TBL] [Abstract][Full Text] [Related]
12. Novel, provable algorithms for efficient ensemble-based computational protein design and their application to the redesign of the c-Raf-RBD:KRas protein-protein interface.
Lowegard AU; Frenkel MS; Holt GT; Jou JD; Ojewole AA; Donald BR
PLoS Comput Biol; 2020 Jun; 16(6):e1007447. PubMed ID: 32511232
[TBL] [Abstract][Full Text] [Related]
13. Quantitative biophysical analysis defines key components modulating recruitment of the GTPase KRAS to the plasma membrane.
Lakshman B; Messing S; Schmid EM; Clogston JD; Gillette WK; Esposito D; Kessing B; Fletcher DA; Nissley DV; McCormick F; Stephen AG; Jean-Francois FL
J Biol Chem; 2019 Feb; 294(6):2193-2207. PubMed ID: 30559287
[TBL] [Abstract][Full Text] [Related]
14. Cryo-EM structure of a RAS/RAF recruitment complex.
Park E; Rawson S; Schmoker A; Kim BW; Oh S; Song K; Jeon H; Eck MJ
Nat Commun; 2023 Jul; 14(1):4580. PubMed ID: 37516774
[TBL] [Abstract][Full Text] [Related]
15. 14-3-3 zeta negatively regulates raf-1 activity by interactions with the Raf-1 cysteine-rich domain.
Clark GJ; Drugan JK; Rossman KL; Carpenter JW; Rogers-Graham K; Fu H; Der CJ; Campbell SL
J Biol Chem; 1997 Aug; 272(34):20990-3. PubMed ID: 9261098
[TBL] [Abstract][Full Text] [Related]
16. B-Raf autoinhibition in the presence and absence of 14-3-3.
Zhang M; Jang H; Li Z; Sacks DB; Nussinov R
Structure; 2021 Jul; 29(7):768-777.e2. PubMed ID: 33711246
[TBL] [Abstract][Full Text] [Related]
17. B- and C-RAF display essential differences in their binding to Ras: the isotype-specific N terminus of B-RAF facilitates Ras binding.
Fischer A; Hekman M; Kuhlmann J; Rubio I; Wiese S; Rapp UR
J Biol Chem; 2007 Sep; 282(36):26503-16. PubMed ID: 17635919
[TBL] [Abstract][Full Text] [Related]
18. The quaternary assembly of KRas4B with Raf-1 at the membrane.
Jang H; Zhang M; Nussinov R
Comput Struct Biotechnol J; 2020; 18():737-748. PubMed ID: 32257057
[TBL] [Abstract][Full Text] [Related]
19. Structural determinants of Ras-Raf interaction analyzed in live cells.
Bondeva T; Balla A; Várnai P; Balla T
Mol Biol Cell; 2002 Jul; 13(7):2323-33. PubMed ID: 12134072
[TBL] [Abstract][Full Text] [Related]
20. RASopathy mutations provide functional insight into the BRAF cysteine-rich domain and reveal the importance of autoinhibition in BRAF regulation.
Spencer-Smith R; Terrell EM; Insinna C; Agamasu C; Wagner ME; Ritt DA; Stauffer J; Stephen AG; Morrison DK
Mol Cell; 2022 Nov; 82(22):4262-4276.e5. PubMed ID: 36347258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
